Our website uses cookies to enhance and personalize your experience and to display advertisements (if any). Our website may also include third party cookies such as Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click the button to view our Privacy Policy.

Mucouspox resurgence in Africa prompts declaration of global health emergency

Mucouspox resurgence in Africa prompts declaration of global health emergency

The World Health Organization (WHO) declared a public health emergency of international concern (PHEIC) on Wednesday due to a rapid increase in mpox cases in more than a dozen African countries. The Democratic Republic of the Congo (DRC) is experiencing the most severe outbreak, with more than 15,600 confirmed cases and 537 deaths reported by the UN agency. This surpasses the lethality of the 2022 mpox outbreak, which previously led to a PHEIC declaration. What you need to know about Mpox Previously known as monkeypox, the virus was renamed in 2022 following concerns raised by health authorities. Key points For…
Read more
Rethinking the Benefits: Moderate Alcohol Consumption Does Not Benefit the Heart or Increase Cancer Risk in Older Adults

Rethinking the Benefits: Moderate Alcohol Consumption Does Not Benefit the Heart or Increase Cancer Risk in Older Adults

A major new study challenges the idea that moderate alcohol consumption offers heart health benefits for older adults. Researchers in Britain tracked more than 135,000 people ages 60 and older for 12 years. The study found that even light alcohol consumption was linked to an increased risk of cancer-related deaths, particularly among those with underlying health conditions or living in low-income areas. These findings support a growing trend toward more stringent alcohol consumption guidelines. Traditionally, light to moderate drinking has been thought to offer some protection against heart disease. This study, however, found no evidence of such benefits in older…
Read more
Danger in delivery: Mail-order drugs at risk in summer heat

Danger in delivery: Mail-order drugs at risk in summer heat

Millions of people rely on convenient mail-order prescriptions for essential medications. However, scorching summer temperatures pose a hidden threat. Excessive heat and humidity can degrade the effectiveness of various medications, putting patients' health at risk. The problem goes beyond seasonal fluctuations. Extreme temperatures, even at other times of the year, can affect the chemical composition of drugs, making them less potent or potentially harmful. This is especially concerning for drugs such as insulin, birth control pills, and life-saving liquid medications used by transplant patients. While mail-order companies often use "weatherproof" packaging, independent studies raise concerns that medications exceed safe temperature…
Read more
Inflation analysis in Spain: Recent trends and changes

Inflation analysis in Spain: Recent trends and changes

The National Institute of Statistics (INE) reported that inflation, which showed a decrease in the level in July, is mainly due to the reduction in electricity prices compared to the previous year. In September, the Consumer Price Index (CPI) reached six tenths, recording an annual increase of 2.8%. This CPI excludes energy and fresh food to avoid excessive fluctuations, and is below the 3% that has been maintained for two months. The IPC caída in September is produced between two months of descent, after the experimental peaks in March, April and May. In July, the CPI reached its lowest level…
Read more
MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

MDMA Therapy Setback: Journal Retracts Study After FDA Rejects Drug

Three research papers exploring MDMA-assisted therapy for PTSD have been retracted by the journal Psychopharmacology. This follows the recent rejection of MDMA for this use by the Food and Drug Administration (FDA). The retracted studies, written by researchers affiliated with Lykos Therapeutics, the company behind the rejected treatment application, were found to involve unethical conduct at one of the research sites. Lykos, however, maintains that the retracted research was not part of their submission to the FDA. This development adds another layer of complexity to the ongoing debate over MDMA-assisted therapy. While some research suggests its potential in treating PTSD,…
Read more
Blood Clotting Risk Doubles With Erythritol Consumption: Insights From Pilot Study

Blood Clotting Risk Doubles With Erythritol Consumption: Insights From Pilot Study

A recent pilot study found that drinking a beverage containing erythritol (an artificial sweetener used to boost the content of stevia and monk fruit and to sweeten low-carb ketogenic products) more than doubled the risk of blood clots in 10 healthy individuals. Blood clots can break off from blood vessels and travel to the heart, triggering a heart attack, or the brain, causing a stroke. Previous research has linked erythritol to an increased risk of stroke, heart attack, and death. Dr. Stanley Hazen, lead author of the study and director of the Cardiovascular Diagnostic and Prevention Center at the Cleveland…
Read more
The importance of early cancer diagnosis in saving lives and reducing treatment costs

The importance of early cancer diagnosis in saving lives and reducing treatment costs

Early detection of cancer is critical to saving lives and mitigating the financial burden associated with treating this disease, health officials say. Understanding the mechanisms underlying this diagnosis becomes increasingly crucial as the incidence of cancer shifts to younger age groups, as highlighted in a report released in January by the American Cancer Society. The report, published in CA: A Cancer Journal for Clinicians, reveals a troubling trend: While the general population in the United States is aging, individuals under age 50 are experiencing an increase in overall cancer incidence from 1995 to 2020. This contrasts with older age groups,…
Read more
Breakthrough peanut allergy treatment program launched in Australia

Breakthrough peanut allergy treatment program launched in Australia

In a groundbreaking initiative, infants with peanut allergies across Australian hospitals will now have access to a life-changing treatment program aimed at building tolerance to this common allergy. The pioneering program, the first of its kind in the world, is a collaboration between the National Centre of Excellence in Allergy (NACE) and the Murdoch Children's Research Institute (MCRI). Known as the ADAPT OIT Program, it is tailored for infants under 12 months who have been diagnosed with a peanut allergy and are under the care of allergy specialists at ten children’s hospitals in five states in Australia. The treatment, provided…
Read more
More and more women in Africa are using long-acting contraceptives, changing their lives

More and more women in Africa are using long-acting contraceptives, changing their lives

Countries with limited budgets typically choose to pay for what are considered more essential health services, such as vaccines, rather than reproductive health, said Dr Ayman Abdelmohsen, head of the family planning division of UNFPA's technical division, because they produce more immediate results. But a recent UNFPA initiative to get low-income countries to shoulder a greater share of the costs has led 44 governments to sign up to a new financing model that commits them to increasing their contributions to reproductive health each year. Despite this, last year saw a significant global shortfall of around $95 million in commodity purchases.…
Read more
Rising Drug Costs: Are Pharmaceutical Benefit Managers to Blame?

Rising Drug Costs: Are Pharmaceutical Benefit Managers to Blame?

For many Americans, the rising tide of prescription drug prices seems like an unstoppable force, threatening to drown household budgets and access to health care. While pharmaceutical companies often shoulder the brunt of the public blame, the web of influence on drug costs is far more intricate. Today, we shine a spotlight on a critical but usually hidden player in this system: pharmacy benefit managers, or PBMs. Rebecca Robbins, a leading investigative reporter specializing in pharmaceuticals for The New York Times, takes us on a deep dive into the world of PBMs. We explore their role as middlemen between drugmakers,…
Read more